President Biden Declares September 2021 National Ovarian Cancer Awareness Month
The official declaration means more funding for research initiatives.
President Joe Biden officially declared September 2021 as National Ovarian Cancer Awareness Month in a briefing last month.
Biden noted that his administration plans to build on the current efforts to eliminate ovarian cancer by supporting investments in research and technology to develop new ways to detect ovarian cancer early and improve treatment strategies.
Although September has been widely recognized as Ovarian Cancer Awareness Month by organizations like the Ovarian Cancer Research Alliance (OCRA), the official observation means funding for the things that matter; Biden also called for the creation of an Advanced Research Projects Agency for Health at the National Institutes of Health (NIH), known as ARPA-H, that would invest $6.5 billion to develop breakthroughs that prevent, detect, and treat cancer and other deadly diseases.1
Did you know?
In 2018, the latest year for which incidence data are available, 19,679 cases of ovarian cancer were reported among women.2
For every 100,000 women, 10 new ovarian cancers were reported.2
Ovarian cancer is the second most common gynecologic cancer in the United States.2
Ovarian cancer causes more deaths each year than any other gynecologic cancer in the United States.2
References
- A Proclamation on National Ovarian Cancer Awareness Month, 2021 | The White House. Published August 31, 2021. Accessed September 13, 2021. www.whitehouse.gov/briefing-room/presidential-actions/2021/08/31/a-proclamation-on-national-ovarian-cancer-awareness-month-2021/
- USCS Data Visualizations. CDC.gov. Published 2021. Accessed September 13, 2021. gis.cdc.gov/Cancer/USCS/#/AtAGlance/
Shift towards neoadjuvant chemotherapy found in ovarian cancer treatment
October 21st 2024A recent study shows a significant decrease in primary cytoreductive surgery utilization for advanced ovarian cancer, as neoadjuvant chemotherapy followed by interval cytoreductive surgery gains acceptance for its noninferior survival outcomes and reduced postoperative morbidity.
Read More
Family history criteria used to predict breast cancer genetic risk variants
September 26th 2024In a recent study, patients with a positive response to the Seven-Question Family History Questionnaire were more likely to present with a pathogenic or likely pathogenic variant in the BRCA1 and BRCA2 genes.
Read More
Offering cervical and colorectal cancer screening at breast cancer screening found effective
August 26th 2024In a recent study, women overdue for cervical cancer and colorectal cancer screening were more likely to receive coverage when offered during their breast cancer screening visit.
Read More
